The dynamic international biotech market is continuously reviewing its target markets for entry or expansion, to optimise its ...

A system-focus is particularly relevant ... demand for independent auditors and help with integrating pharmacovigilance into Quality Management Systems. This has given Derek the opportunity ...

Regulators such as the Food and Drug Administration (FDA) and European Medicines Agency (EMA) have different signal management expectations. Module IX of the EMA’s Good Pharmacovigilance ...

The global quest to prevent childhood cancer deaths has a long history. For decades, efforts have centred on driving innovation to produce more effective therapies, improve understanding in how and ...

Learn more about whether Medpace Holdings, Inc. or Repligen Corporation is a better investment based on AAII's A+ Investor ...

Objective: This study aims to identify the drugs most commonly associated with kidney stone-related adverse events using data from the FDA Adverse Event Reporting System ... reference for ...

Complaints provide insights to improve product quality, ensure compliance, and drive growth. Cardinal Health is transforming ...

As drug safety teams face increasing regulatory demands and growing data volumes, leveraging artificial intelligence (AI)-driven tools has become essential for improving accuracy, efficiency and ...

Strategies to enhance virtual care through quality assurance frameworks, technological innovation, and provider support were ...

Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register ...

Experts discuss the role of continuous glucose monitoring (CGM)-derived metrics, particularly glucose management indicator (GMI), in the new Healthcare Effectiveness Data and Information Set (HEDIS) ...

The contract will support R&D of high-quality APIs for substance use disorders and mental health conditions, starting with synthesis and scale-up of psilocybin, which is derived from mushrooms.